Molecular chaperone therapy- the future in cancer.
作者信息
Shehzad Abdul Moid, Dawani Om, Munir Shehryar, Hussain Syed Anas
机构信息
Medical Student, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
出版信息
Infect Agent Cancer. 2012 Aug 13;7(1):20. doi: 10.1186/1750-9378-7-20.
Abstract
摘要
相似文献
1
Molecular chaperone therapy- the future in cancer.
Infect Agent Cancer. 2012 Aug 13;7(1):20. doi: 10.1186/1750-9378-7-20.
2
A novel method to assay molecular chaperone activity of HSP70: evaluation of drug resistance in cancer treatment.
Biosens Bioelectron. 2013 Sep 15;47:75-9. doi: 10.1016/j.bios.2013.02.042. Epub 2013 Mar 14.
3
Chaperone therapy for molecular pathology in lysosomal diseases.
Brain Dev. 2021 Jan;43(1):45-54. doi: 10.1016/j.braindev.2020.06.015. Epub 2020 Jul 29.
4
[Preparation of chaperone-antigen peptide vaccine derived from human gastric cancer stem cells and its immune function].
Zhonghua Zhong Liu Za Zhi. 2017 Feb 23;39(2):109-114. doi: 10.3760/cma.j.issn.0253-3766.2017.02.007.
5
Biologic activities of molecular chaperones and pharmacologic chaperone imidazole-containing dipeptide-based compounds: natural skin care help and the ultimate challenge: implication for adaptive responses in the skin.
Am J Ther. 2012 Mar;19(2):e69-89. doi: 10.1097/MJT.0b013e3181e71fb7.
6
Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease.
Brain Dev. 2013 Jun;35(6):515-23. doi: 10.1016/j.braindev.2012.12.002. Epub 2013 Jan 3.
7
A survey and analysis of the role of molecular chaperone proteins and imidazole-containing dipeptide-based compounds as molecular escorts into the skin during stress, injury, water structuring and other types of cutaneous pathophysiology.
Int J Cosmet Sci. 2011 Feb;33(1):1-16. doi: 10.1111/j.1468-2494.2010.00601.x.
8
Chemical chaperone therapy: luciferase assay for screening of β-galactosidase mutations.
Mol Genet Metab. 2010 Dec;101(4):364-9. doi: 10.1016/j.ymgme.2010.08.012. Epub 2010 Aug 18.
9
Fibroblast screening for chaperone therapy in beta-galactosidosis.
Brain Dev. 2006 Sep;28(8):482-6. doi: 10.1016/j.braindev.2006.02.002. Epub 2006 Apr 17.
10
Characterization of the Relationship between the Chaperone and Lipid-Binding Functions of the 70-kDa Heat-Shock Protein, HspA1A.
Int J Mol Sci. 2020 Aug 20;21(17):5995. doi: 10.3390/ijms21175995.
引用本文的文献
1
A Bioinformatic Approach for the Identification of Molecular Determinants of Resistance/Sensitivity to Cancer Thermotherapy.
Oxid Med Cell Longev. 2019 Nov 11;2019:4606219. doi: 10.1155/2019/4606219. eCollection 2019.
本文引用的文献
1
Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy.
Mol Cancer Ther. 2012 Feb;11(2):475-84. doi: 10.1158/1535-7163.MCT-11-0755. Epub 2011 Dec 5.
2
Molecular chaperones in mammary cancer growth and breast tumor therapy.
J Cell Biochem. 2012 Apr;113(4):1096-103. doi: 10.1002/jcb.23461.
3
Molecular chaperones: toward new therapeutic tools.
Biomed Pharmacother. 2011 Jul;65(4):239-43. doi: 10.1016/j.biopha.2011.04.025. Epub 2011 Jun 12.
4
Hsp90 as a therapeutic target in patients with oesophageal carcinoma.
Expert Opin Ther Targets. 2010 Mar;14(3):317-28. doi: 10.1517/14728221003621278.
5
Heat shock protein 90: the cancer chaperone.
J Biosci. 2007 Apr;32(3):517-30. doi: 10.1007/s12038-007-0051-y.
6
Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors.
Endocr Relat Cancer. 2006 Dec;13 Suppl 1:S125-35. doi: 10.1677/erc.1.01324.
7
Heat shock proteins in cancer: chaperones of tumorigenesis.
Trends Biochem Sci. 2006 Mar;31(3):164-72. doi: 10.1016/j.tibs.2006.01.006. Epub 2006 Feb 17.
8
Heat shock proteins as emerging therapeutic targets.
Br J Pharmacol. 2005 Nov;146(6):769-80. doi: 10.1038/sj.bjp.0706396.
9
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications.
Cell Stress Chaperones. 2005 Summer;10(2):86-103. doi: 10.1379/csc-99r.1.
10
Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation.
Exp Cell Res. 2005 Jul 1;307(1):212-23. doi: 10.1016/j.yexcr.2005.03.003. Epub 2005 Apr 1.
Zotero 插件